ESTHER GILLEN: Open Payments
NPI 1134792179 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 22 payments from 15 companies in 2025. Trend: 2023 $907 · 2024 $687 · 2025 $558
Food & beverage: $438Education: $120
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $135 |
| Celgene Corporation | 2 | $65 |
| Aveo Pharmaceuticals, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: REBLOZYL, FOTIVDA, VERZENIO, OJJAARA, KEYTRUDA, Tibsovo, clonoSEQ, RYBREVANT.
Industry payments across TX — which companies pay providers there.
